IL6 and metabolic dysfunction-associated steatohepatitis: The NASH-NS group showed an increased expression of interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), and interferon γ (IFN-γ) in the liver compared with the CON-NS group.